ABSTRACT: A novel metabolomic method based on gas chromatography-mass spectrometry was applied to investigate serum metabolites in response to dietary Gln supplementation in piglets. Sixteen, 21-d-old pigs were weaned and assigned randomly to 2 isonitrogenous diets: 1) Gln diet, which contained 1% L-Gln (as-fed basis), and 2) control diet, which contained LAla to make this diet isonitrogenous with the Gln diet. Serum samples were collected to characterize metabolites after a 30-d treatment. In addition, 4 liver samples per treatment were collected to examine enzyme activity and gene expression involved in metabolic regulation. Results indicated that 12 metabolites were altered (P < 0.05) by Gln treatment, including carbohydrates, AA, and fatty acids. A leave-one-out cross validation of random forest analysis indicated that Pro was most important among the 12 metabolites. Thus, these data demonstrate that the control and Gln-supplemented pigs differed (P < 0.05) in terms of metabolism of carbohydrates, Pro, Tyr, and glycerophospholipids. Principal component analysis yielded separate clusters of profi les between the Gln and control groups. Metabolic enzyme activities of Ala aminotransferase and hexokinase increased by 26.8% (P = 0.026) and 26.2% (P = 0.004) in the liver of Gln-supplemented pigs vs. control, respectively, whereas pyruvate kinase (PK) activity decreased by 29.1% (P = 0.001). The gene expression of PK in the liver decreased by 66.1% (P = 0.034) by Gln treatment for 30 d. No differences were observed for the mRNA abundance of mammalian target of rapamycin and PPARγ. On the basis of these data, Gln treatment affected carbohydrate, lipid, and AA metabolism in the whole body of the early weaned piglets. These fi ndings provide insight into specifi c metabolic pathways and lay the groundwork for the complex metabolic alteration in response to dietary Gln supplementation of pigs.
INTRODUCTION
Glutamine serves as a major energy substrate for rapidly dividing cells and a building block for polypeptides and proteins (Rhoads and Wu, 2009) , as well as an essential precursor of bioactive molecules (Boza et al., 2000) . Glutamine also has diverse regulatory roles in gene and protein expression (Curi et al., 2005; Xi et al., 2011) . Endogenous production of Gln in mammals is insuffi cient during adverse conditions, and there is evidence that Gln supplementation might be needed in diets fed to young animals during malnutrition (Wu et al., 1996; Chamorro et al., 2010) .
Metabolomics, which is defi ned as the quantitative measurement of small molecular metabolites in a biological sample, has offered novel insights into the effects of diets or drugs by measuring and mathematically modeling changes in the levels of metabolic products (Nicholson and Lindon, 2008; He et al., 2009) . Readily accessible metabolites raise the possibility of identifying biomarkers in specifi c physiological states, such as stress and disease (Rowan et al., 2007) . Metabolic fi ngerprints can be obtained by spectroscopy or nuclear magnetic resonance (Nicholson et al., 2004) .
Gas chromatograph-mass spectroscopy (GC-MS) is an extensively used analytical technique for metabolic profi ling in a variety of biological fl uids (Li et al., 2007) . Some potential biomarkers in the serum and urine have been successfully identifi ed by using the GC-MS-based technology (Li et al., 2007; Qiao et al., 2011) .
At present, there is limited information on the effects of Gln supplementation on serum metabolites in mammals. The aim of this work was to characterize the serum profi le of young animals to examine the extent of metabolic changes caused by dietary Gln supplementation using GC-MS techniques combined with multivariate data analysis. Activities of metabolic enzymes in the liver and mRNA abundance of genes related to nutrient metabolism were also measured.
MATERIALS AND METHODS
All procedures were approved by the University of Zhejiang Institutional Animal Care and Use Committee.
Piglets, Diets, Housing, and Experimental Design
Sixteen 21-d-old healthy female piglets (Duroc × Landrace × Large Yorkshire) with similar BW (5.75 ± 0.57 kg) from 4 litters (4 piglets/litter) were allotted to the Gln group and control group (8 piglets/treatment). The control and Gln groups refl ected supplementation with 1.22% Ala (wt/wt, as-fed basis; isonitrogenous control) and 1% Gln (wt/wt, as-fed basis) to the basal diet, respectively. The percentage of supplemental Gln and the choice of Ala for an isonitrogenous control were based on the research by Wu et al. (1996) and Wang et al. (2008a) . The basal diet was formulated to meet the recommendations of the NRC (1998), and the ingredients and analyzed composition of the basal diet are shown in Table 1 . Alanine and Gln were added to the basal diet at the expense of corn. Pigs were allowed ad libitum access to feed and housed individually (0.6 × 1.2-m pens) in an environmentally controlled facility (25°C ± 1°C, 60% relative humidity, 12-h dark and 12-h light cycle) with concrete, slotted fl oors.
Sampling and Storage
At the end of the 30-d supplementation period, blood samples (5 mL) were collected by venipuncture of the precaval vein between 0800 and 1000 h, following a 12-h period of feed deprivation to avoid the residual effect of the preceding meal on serum metabolites. Blood samples were centrifuged at 4°C at 1,000 × g for 10 min, and serum was subsequently stored in 1-mL aliquots at −80°C until further analyses. Four pigs per treatment were then euthanized by inhalation of anesthetic isofl urance via facial mask. Liver sections (approximately 15 g) were frozen immediately in liquid N and stored at −80°C until enzyme activity assay and isolation of total RNA. D3, 385 IU; vitamin E, 70 IU; vitamin K, 3.36; vitamin B1, 3.43; vitamin B2, 8.75; vitamin B6, 5.15; vitamin B12, 0.04; 17.15; niacin, 36; folic acid, 1.70; biotin, 0.26. 2 Analyzed values; g/kg unless otherwise specifi ed.
3 Asp: Asp + Asn.
4 Glu: Glu + Gln.
Specimen Processing
Serum samples were thawed at room temperature and vortexed for 15 s, after which 100 μL of the serum were transferred into 1.5-mL Eppendorf tubes. Up to 900 μL of a mixture of methanol and deionized water (8/1, vol/vol) and 75 μL of 2-chloro-l-phenylalanine (0.1 mg/mL) as internal standards were added to each sample and vortexed for 10 min. The mixtures were ultrasonicated at ambient temperature (25°C to 28°C) for 5 min and subsequently centrifuged at 12,000 × g for 10 min at 4°C, after which 0.8 mL of the supernatant fraction was separately collected from each sample into 4-mL test tubes. The collected supernatant fl uid was concentrated to complete dryness in a Turbovap N evaporator (Zymark, Hopkinton, MA) at 50°C for 30 min. The dried samples were then derivatized with the addition of 100 μL bis(trimethylsilyl)-trifl uoroacetamide with 1% trimethylchlorosilane into each vial. The mixture was left to react for 1 h in an oven at 90°C. After incubation, the samples were again vortexed for 1 min in preparation for GC-MS analysis (Xue et al., 2008) .
GC-MS Analysis
Analysis was performed on an Agilent 6980 GC system equipped with a 30.0 m × 0.25 mm i.d. fused-silica capillary column with a 0.25-μm HP-5MS stationary phase (Agilent Technologies, Shanghai, China). Helium was used as the carrier gas at a constant fl ow rate of 1 mL/min through the column (Xue et al., 2008 ). An injection volume of 1 μL was run under the splitless mode. The injector temperature was maintained at 250°C. The column temperature was initially kept at 60°C for 3 min and then increased to 140°C at a rate of 7°C/min, where it was held for 4 min and further increased to 300°C at a rate of 5°C/min and maintained for 1 min. The column effl uent was introduced into the ion source of an Agilent 5973 mass selective detector (Agilent Technologies). The MS quadrupole temperature was set to 150°C, and the ion source temperature was set to 230°C. Masses were acquired from a mass-to-charge ratio (m/z) of 45 to 500 at a mass accuracy of 0.1 atomic mass units. The acceleration voltage was turned on after a solvent delay of 6 min.
Biochemical Measurements by Detection Kits
The serum metabolites measured included glucose, high-density lipoprotein (HDL), Gln, total AA (TAA), albumin, total protein, and blood urea N. All assays were performed utilizing the Automatic Biochemical Analyzer (Beckman, Miami, FL) according to the manufacturer's instructions (Jiancheng Bioengineering Ltd, Nanjing, China).
Tissue Preparation and Enzyme Assays
A portion of liver was rapidly thawed and manually homogenized using a glass homogenizer with a glass pestle. All procedures were performed on ice. Homogenates were centrifuged, and the supernatant fraction was diluted to an appropriate concentration. The resultant supernatant fractions were collected for the assay of activities of alkaline phosphatase (AKP, EC 3.1.3.1), Gln synthetase (GS, EC 6.3.1.2), hexokinase (HK, EC 2.7.1.1), pyruvate kinase (PK, EC 2.7.1.40), Ala aminotransferase (ALT, EC 2.6.1.2), Asp aminotransferase (AST, EC 2.6.1.1), and γ-glutamyl transpeptidase (γ-GT). These enzyme activities were evaluated using the detection kits following the manufacturer's instructions. Kits were provided by Jiancheng Bioengineering.
RNA Extraction and Quantitative Real-Time PCR
Total RNA was extracted from jejunum using Trizol Reagent (Invitrogen Life Technologies, Carlsbad, CA) according to the manufacturer's instructions. Firststrand cDNA was synthesized using the SuperScript II RTase with random primers and an Rnase inhibitor (Invitrogen Life Technologies) as per the manufacturer's instructions. Relative abundance of mammalian target of rapamycin (mTOR), PPARγ, and PK-mRNA were performed using the iQ5 Multicolor Real-Time PCR Detection System (Bio-Rad, Hercules, CA) and SYBR Premix Ex Taq Kit (Takara Biotechnology Co. Ltd., Dalian, China). Primers for pig mTOR (GenBank accession number XM003127584), PPARγ (GenBank accession number NM214379), PK (GenBank accession number XM001926810), and the reference gene glyceraldehyde-3-phosphate dehydrogenase (GADPH; Genbank accession number NM017008) were designed using Primer Premier 6.0 (Premier, Ontario, Canada). The sequences were as follows: mTOR, forward 5′ CATGCCATCGCCACTGAGGAC 3′, reverse 5′ CAGCTGCCACTCCCCAAGTTTCA 3′; PPARγ, forward 5′ GTGGAGACCGCCCAGGTTTG 3′, reverse 5′ GGGAGGACTCTGGGTGGTTCA 3′; PK, forward 5′ GAGGAGTCTTCCCTGTGCTCTAC 3′, reverse 5′GC-CACGGAGTTTTCCGCTTTCGA 3′; and GADPH, forward 5′ GGCAAATTCCACGGCACAGTCA 3′, reverse 5′ CTCGCTCCTGGAAGATGGTGAT 3′. All experiments were repeated in triplicate. The relative quantifi cation of target gene expression was evaluated by normalizing its signal to that of GADPHusing the 2−∆∆CT method (Livak and Schmittgen, 2001 ). The fold difference in the relative gene expression of the target was calculated as the 2−∆∆CT value.
Data Analyses
All the collected data were employed for the analysis. The AMDIS software [National Institute of Standards and Technology (NIST), Gaitherburg, MD] was used for the peak deconvolution, and NIST mass spectral library -tegrated peak areas of multiple derivative peaks belonging to the same compound were summed and considered as a single compound. A data matrix was then created -ing the relative area values of the peaks. The ratio of the peak area of each compound to the corresponding internal standard was calculated as the response.
pression in weaned piglets, a 2-sample t-test with an alpha level of P < 0.05 was used to determine differences in metabolite concentrations between the 2 groups. False discovery rates (FDR) were determined from the P-value using the Benjamini-Hochberg (BH) method. The sigadded to leave-one-out cross validation (LOOCV) of decrease in accuracy was used to measure the importance in the Z-score plot. The Z-score analysis scaled each metabolite according to a reference distribution. Each sample was centered by the reference mean and scaled by the reference standard deviation. Therefore, the deviation of different metabolite expressions from the reference can be examined. The Z-score is expressed as
where x is a raw score to be standardized and m and are the mean and SD of the reference population, respectively.
Principal component analysis (PCA), a data visualization method, was used to differentiate the different -ty) of samples was evaluated by the area under the curve (AUC) of the receiver operating characteristic (ROC) curves. Data analyses were performed using Matlab (The Mathworks, Natick, MA).
The serum metabolites measured by detection kits, activities of metabolic enzymes, and relative expression , and PK were evaluated by independent-sample t-tests (SPSS, Chicago, IL) as appropriate. The results are presented as the mean ± SEM. P < 0.05.
RESULTS

Piglet Performance
nal BW of the control and Gln-supplemented pigs were 14.7 ± 1.12 and 15.4 ± 1.24 kg, respectively. Glutamine P = 0.056) increase in ADG (Table 2 ), but it had no effects on overall ADFI (P = 0.84) or G:F (P = 0.18).
Four injections of the same serum sample were consecutively injected into the GC-MS system to test the stability of sample injection, and the data indicated stable retention time with no drift in any of the peaks. The samples of the same serum. Relative SD values of the peak area were less than 10%. Representative GC-MS TIC chromatograms of samples from the control and Gln treatments are shown in Figure 1 . The majority of the as endogenous metabolites on the basis of the NIST mass spectra library. Table 3 shows the 72 signals autoiden--tation patterns composed of all the fragment ions with a standard mass chromatogram. These metabolites are known to be involved in multiple biochemical processes.
A total of 12 metabolites were different between the 2 treatments (Table 4 ). The relative concentrations of the 12 metabolites are shown as a Z-score plot (control pigs as the reference) in Figure 2 . The plot revealed the robust metabolic alterations in Gln-supplemented pigs 2.33). Greater serum concentrations of acetic acid, glycerol, mannonic acid lactone, d-fructose, and d-xylose were found in the control pigs. In contrast, dimethylmalonic acid, 2-hydroxybutyric acid, aminomalonic acid, α-methyltyrosine, Pro, octadecanoic acid, and Tyr were present in greater concentrations in Gln-supplemented pigs. Random forest was run on all 16 samples using a LOOCV. It was observed that Pro seemed to be most important to the classifi cation of the 2 treatments.
Principal Component Analysis
A multivariate PCA analysis based on the profi les of 12 signifi cant metabolites between control and Glnsupplemented pigs demonstrated 2 distinct clusters relating to the group difference from the score plot ( Figure  3 ). Principal component 1 (PC 1) and PC 2 accounted for 78.3% of the variance in the experiment. The corresponding PCA loading plot is shown in accordance with PC 1 and 2. The PCA model was subjected to ROC analysis using the cross-validated predicted y values. The sensitivity and specifi city tradeoffs were summarized for each variable by the AUC and calculated by the trapezoidal rule. It was observed that the PCA model was of high reliability (AUC = 1).
Serum Metabolites Measured by Detection Kits
Serum metabolites of control and Gln-supplemented pigs are presented in Table 5 . The concentrations of TAA and total protein were greater (P < 0.05) in the serum of Gln-supplemented pigs vs. the control, but concentrations of glucose, HDL, Gln, albumin, and urea were not altered (P > 0.05). These data were consistent with those on the relative intensities of glucose, Gln, and urea in the GC-MS analysis. 
in the Liver of Pigs
Among all the metabolic enzymes studied (Table 6) , ALT and HK activities increased by 26.8% (P = 0.026) and 26.2% (P = 0.004) in the liver of Gln-supplemented pigs compared with the control pigs, whereas PK activity decreased by 29.1% (P = 0.001). The activities of AKP, AST, GS, and -GT were not affected by Gln treatment (P > 0.05).
mTOR, and PPAR mRNA
The gene expression of PK was downregulated in the liver by Gln treatment for 30 d (Figure 4) . The mRNA level of PK decreased by 66.1% (P = 0.034). No differ- 2 Adjusted P-value by the Benjamini-Hochberg (BH) method was used to determine false discovery rates.
PPAR after the 30-d treatment (P > 0.05).
Proposed Metabolic Pathway Regulation by Gln Treatment
This is the proposed metabolic pathway regulation by Gln treatment. Wiring diagrams were manually linked 2 HDL = high-density lipoprotein; TAA = total AA.
3 Control = 1.22% Ala supplementation as an isonitrogenous control.
4 Gln = 1% Gln supplementation.
together to form a metabolic network that involved 4 canonical KEGG pathways, namely carbohydrate metabolism, Arg and Pro metabolism, Tyr metabolism, and glycerophospholipid metabolism ( Figure 5 ).
DISCUSSION
Metabolomics is a systems approach that is used to understand global changes of metabolites in mammals in response to alterations in nutrition, genetics, environment, and gut microbiota (Nicholson et al., 2004; Wang et al., 2007 Wang et al., , 2008b . In the present study, GC-MS-based metabolomics was applied, which identifi ed 12 altered metabolites in response to dietary Gln supplementation. These different metabolites are potentially involved in several Kyoto Encyclopedia of Genes and Genomes (KEGG) metabolic pathways (Panagiotou et al., 2007; Antonov et al., 2008) . It may be much more informative to consider the global metabolic network for the interpretation of the metabolites. The subsequent multivariate analysis separated the samples into their respective treatments.
Serum concentrations of Pro, Tyr, TAA, and total protein were increased in Gln-supplemented pigs in the present study, which further confi rms the role of Gln in modulating AA metabolism and protein synthesis. Proline can be synthesized from Gln in the body (Watford, 2008; Wu et al., 2008 Wu et al., , 2011 . The uptake of Gln in vivo and release of Pro to the portal vein from the small intestine have been observed in weanling pigs (Wu et al., 1994) and humans (Fujita and Yanaga, 2007) . It is generally recognized that the majority of Pro synthesis within the body occurs in the intestine (Bertolo et al., 2003) via the Glu/pyrroline-5-carboxylate synthase pathway, which is restricted to the intestine (Watford, 2008) . Approximately 7% of Gln carbon metabolized within the rat small intestine was used for Pro synthesis (Windmueller and Spaeth, 1974) . Proline synthesis from Glu in the intestine accounted for approximately 40% of the Pro accumulated in the carcass of piglets (Murphy et al., 1996) . In addition, dietary Gln supplementation maintains the integrity of intestinal morphology (Wu et al., 1996; Wang et al., 2008a) and elevates the digestibility of nutrients (including Pro) in early weaned pigs (Xiao et al., 2012) . These fi ndings suggest that more Pro was absorbed from the diet in the gastrointestinal tract and released to the bloodstream in Gln-supplemented pigs. In support of this hypothesis, serum concentrations of Tyr and TAA were greater in the Gln-supplemented pigs than in the control pigs. Proline can promote body growth and plays versatile roles in cell metabolism and 1 Abbreviations: AKP = alkaline phosphatase; ALT = Ala aminotransferase; AST = Asp aminotransferase; GS = Gln synthetase; HK = hexokinase; PK = pyruvate kinase; γ-GT = γ-glutamyl transpeptidase.
2 Control = 1.22% Ala supplementation as an isonitrogenous control.
3 Gln = 1% Gln supplementation.
4 n = 4/treatment. physiology, including protein synthesis, gene expression and cell differentiation, Pro signaling, cellular redox reactions, and antioxidative capacity . Therefore, these observations could help explain the reason for the nonsignifi cant increase in ADG of Glnsupplemented pigs, which agrees with previous reports (Samuels et al., 1989; Kirchgessner et al., 1995) .
Glutamine promotes protein synthesis (Meisse et al., 1999) and inhibits protein breakdown (Maclennan et al., 1988) in mammals. Accordingly, the serum total protein concentration was increased by Gln treatment in the present study. Glutamine regulates protein turnover through cellular mTOR signaling (Wu, 2009) . The mTOR, a highly conserved Ser/Thr protein kinase, administrates an unusually abundant and diverse set of readouts related to protein synthesis (Liao et al., 2008) and cell growth (Schmelzle and Hall, 2000) . The mTOR signaling pathway is sensitive to nutrients, stress, and intracellular energy state (Liao et al., 2008) . Nonetheless, using the current experimental conditions, we did not fi nd significant differences in the expression of mTOR in the liver as a result of dietary Gln supplementation. This fi nding confi rms that the mTOR pathway is regulated in young pigs as a result of posttranslational protein modifi cations (Kimball et al., 2000; O'Connor et al., 2004) . Results of previous studies demonstrated that protein abundance of mTOR in the liver of pigs is not modulated by feeding (Suryawan et al., 2006) , whereas hepatic protein synthesis through an mTOR-dependent process can be stimulated by feeding (Kimball et al., 2000) .
An intriguing observation from the present work is that serum concentrations of D-fructose and D-xylose were decreased in Gln-supplemented pigs, indicating a change in carbohydrate metabolism. Fructose can be converted to glucose via phosphorylation to fructose-Lphosphate or fructose-6-phosphate, catalyzed by fructokinase and HK, respectively (White and Landau, 1965) . We noted that HK activity increased by 26.2% in the liver of Gln-supplemented pigs. In this case, elevated HK activity might have resulted in increased conversion of fructose to fructose-6-phosphate, then formation of glucose. D-Xylose is related to pentose and glucuronate interconversions and can be converted to pyruvate through a series of metabolic processes in the KEGG metabolic pathway, which might infl uence the tricarboxylic acid (TCA) cycle or pyruvate metabolism. It is well known that PK is a key regulatory glycolytic enzyme involved in the conversion of phosphoenolpyruvate to pyruvate in a variety of species, and PK activity can modify the rate of glycolysis (Stifel et al., 1969) . Remarkably, the present data indicate that both PK activity and the expression of PK decreased in the liver of Gln-treated pigs, which indicates that the glycolytic pathway was decreased and the model of energy production was modulated. This fi nding indicates that ATP production from glycolytic pathway was decreased and more Gln entered TCA cycle to generate ATP in Gln-supplemented pigs. Accordingly, ALT activity increased in Gln-supplemented pigs. Glutamine is changed to α-ketoglutarate by ALT after fi rst being converted to Glu (Board et al., 1990) , which indicates ALT is connected to Gln metabolism. Thus, we propose that Gln treatment can mediate carbohydrate metabolism through the regulation of glycolysis, the TCA cycle, and the pentose pathway.
Changes in serum glycerol and octadecanoic acid concentrations could be a result of accelerated decomposition of fat for energy and the decrease of free fatty acid consumption by the liver (Galli et al., 1999) . The expression of the lipogenic transcription factor PPARγ in the liver was not changed by Gln treatment in the present experiment. It is concluded that lipid synthesis was not altered in Gln-supplemented pigs compared with control pigs. As a member of the nuclear receptor family, the activation of PPARγ is mediated by lipid metabolites, vitamins, and direct binding of steroid and thyroid hormones (Chawla et al., 2001 ). Further research is needed to clarify the action of Gln on lipid and fatty acid metabolism in the whole body of weanling pigs.
In conclusion, a novel GC-MS-based metabolomic method was applied to study the metabolic changes in response to dietary Gln supplementation in early weaned piglets. The results of this study demonstrate that the serum metabolite profi les of Gln-supplemented pigs differed from those of the control pigs, which were refl ected in the metabolism of Arg, Pro, Tyr, and glycerophospholipid intermediates. An unexpected observation was the combination of the decreased serum concentrations of D-fructose and D-xylose, decreased PK mRNA abundance and activity, and the increased HK activity in the liver of Gln-supplemented pigs, which coincided with decreased glycolysis and altered carbohydrate metabolism in the body. These observations indicate that serum metabolic profi ling could be used to investigate nutritional differences in mammals and reveal that supplementing early weaned pigs with dietary Gln resulted in distinct metabolic changes. The metabolic alteration we detected will be useful to develop a comprehensive view of Gln function in the body.
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